Article info
PDFPelvic inflammatory disease
Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial
- Correspondence to: J D C Ross Whittall Street Clinic, Whittall Street, Birmingham B4 6DH, UK; jonathan.ross{at}hobtpct.nhs.uk
Citation
Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial
Publication history
- Accepted May 11, 2006
- First published May 24, 2006.
Online issue publication
May 13, 2016
Article Versions
- Previous version (13 May 2016).
- Previous version (13 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Sexually Transmitted Infections